Allogene Stock Story

Allogene investor sentiment overview provides quick insight into current market opportunities from investing in Allogene Therapeutics. The current market sentiment together Allogene Therapeutics' historical and current headlines can help investors to time the market. Many technical investors use Allogene Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out Trending Equities.
  
Refresh
Allogene Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Allogene daily returns and investor perception about the current pice of Allogene Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Sale by Owen Witte of 10000 shares of Allogene Therapeutics
Filed transaction by Allogene Therapeutics Inc director. General open market or private sale of non-derivative or derivative security

Allogene insider trading alert for sale of common stock by Owen Witte, the corporate stakeholder, on 23rd of June 2022. This event was filed by Allogene Therapeutics Inc with SEC on 2022-06-23. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Allogene Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Allogene Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Allogene Therapeutics Fundamental Analysis

We analyze Allogene Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allogene Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allogene Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price to Sales

Price to Sales Comparative Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Peers

Your Trending Equities

T  1.65   
0%
47.0%
HD  1.38   
0%
39.0%
AAPL  1.30   
0%
37.0%
UPS  0.67   
0%
19.0%
CVS  0.16   
0%
4.0%
C  0.23   
6.0%
0%
S  0.28   
8.0%
0%
IBM  0.81   
23.0%
0%
WFC  1.17   
33.0%
0%
MET  1.27   
36.0%
0%
INTC  1.30   
37.0%
0%
TGT  1.81   
52.0%
0%
CVX  1.97   
56.0%
0%
BBY  2.47   
70.0%
0%
AA  3.31   
95.0%
0%
AAL  3.48   
100.0%
0%
Check out Trending Equities. Note that the Allogene Therapeutics information on this page should be used as a complementary analysis to other Allogene Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Tools for Allogene Stock

When running Allogene Therapeutics price analysis, check to measure Allogene Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allogene Therapeutics is operating at the current time. Most of Allogene Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allogene Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Allogene Therapeutics' price. Additionally, you may evaluate how the addition of Allogene Therapeutics to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go